… a genome-wide association study for association of disease … Genome-wide association
studies (GWAS) of CSF … for clinical AD diagnosis in our cohort (over and above commonly used …

… in cerebrospinal fluid (CSF) and plasma to predict longitudinal cognition status using
Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort. … in genome-wide association studies …

… Although genome-wide association studies have identified … genome-wide SNP-SNP interaction
on cerebrospinal fluid Aβ 42 … a genome-wide epistasis detection study in the ADNI cohort …

… Genome-wide association studies have successfully … AD CSF biomarkers (Aβ42, t-tau, p-tau
and t-tau/ Aβ42 ratio) … validation cohorts (ADC cohort: 4 rs4637258, P = 0.01; ADNI cohort …

… The phenotype used in this paper is CSF Qt. Using … the variance explained by interaction
term on T-tau/Aβ42. The … ., “Genome-wide association and interaction studies of CSF …

… contribution to AD risk was identified by genome-wide … Later studies have shown that the
CSF Aβ42/40 ratio may be … of rates of change of CSF biomarkers in ADNI. Reproduced with …

… AD biomarkers, we examined the interaction effects (… higher biomarker ratios (CSF pTau/Aβ
42 , p = 0.0066; CSF tTau/… of drinking and CSF AD biomarkers (p-tau/Aβ42 and t-tau/Aβ42) (…

… both cohorts and correlated with AD biomarkers (CSF Aβ42, … .3, 10, 11 In addition,
genome-wide association studies have … Subject demographics of the discovery and ADNI cohorts …

… Genome-wide association studies (GWAS) have identified more than 50 genetic risk factors
… study on the genome-wide network-based pathway analysis of CSF t-tau/Aβ42 ratio in the …

… by two large population cohort studies, the Avon Longitudinal … E (APOE), genome wide
association studies (GWAS) have … MRI techniques with cerebrospinal fluid and neuroradiology …